These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36183212)

  • 1. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients.
    Sulaiman H; Roberts JA; Abdul-Aziz MH
    Farm Hosp; 2022 Mar; 46(3):182-190. PubMed ID: 36183212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial.
    Ewoldt TMJ; Abdulla A; Rietdijk WJR; Muller AE; de Winter BCM; Hunfeld NGM; Purmer IM; van Vliet P; Wils EJ; Haringman J; Draisma A; Rijpstra TA; Karakus A; Gommers D; Endeman H; Koch BCP
    Intensive Care Med; 2022 Dec; 48(12):1760-1771. PubMed ID: 36350354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
    Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
    BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic drug monitoring of beta-lactam antibiotics in critically ill adult patients].
    Závorszky L; Rádler A; Galgóczi J; Tóth B; Csomós Á; Erőss A; Farkas R; Karvaly G; Holub L; Szabó BG; Lakatos B
    Orv Hetil; 2023 Dec; 164(48):1904-1911. PubMed ID: 38043089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Pai Mangalore R; Ashok A; Lee SJ; Romero L; Peel TN; Udy AA; Peleg AY
    Clin Infect Dis; 2022 Nov; 75(10):1848-1860. PubMed ID: 35731853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
    Williams P; Cotta MO; Roberts JA
    Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
    Roberts JA; Paul SK; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J;
    Clin Infect Dis; 2014 Apr; 58(8):1072-83. PubMed ID: 24429437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
    Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
    Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Lactam antimicrobial  pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study.
    Lonsdale DO; Kipper K; Baker EH; Barker CIS; Oldfield I; Philips BJ; Johnston A; Rhodes A; Sharland M; Standing JF
    J Antimicrob Chemother; 2020 Dec; 75(12):3625-3634. PubMed ID: 32989452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
    Heffernan AJ; Mohd Sazlly Lim S; Lipman J; Roberts JA
    Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100970. PubMed ID: 34728411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
    Dhaese S; Van Vooren S; Boelens J; De Waele J
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
    Sadilová K; Halačová M; Černý D
    Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
    Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
    Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA
    Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
    Heffernan AJ; Sime FB; Taccone FS; Roberts JA
    Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections.
    Abdul-Aziz MH; Lipman J; Roberts JA
    Crit Care; 2017 Nov; 21(1):283. PubMed ID: 29157264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.